APA (7th ed.) Citation

Brada, M. D., Karakulak, T., Schraml, P., Haberecker, M., Rutishauser, D., Ross, J. S., . . . Moch, H. AXL and SRC in clear cell renal cell carcinoma: Absence of mutations, rare alternative splicing events, but association of protein expression with poor prognosis. Wiley.

Chicago Style (17th ed.) Citation

Brada, Muriel D., Tülay Karakulak, Peter Schraml, Martina Haberecker, Dorothea Rutishauser, Jeffrey S. Ross, Daniel Eberli, and Holger Moch. AXL and SRC in Clear Cell Renal Cell Carcinoma: Absence of Mutations, Rare Alternative Splicing Events, but Association of Protein Expression with Poor Prognosis. Wiley.

MLA (9th ed.) Citation

Brada, Muriel D., et al. AXL and SRC in Clear Cell Renal Cell Carcinoma: Absence of Mutations, Rare Alternative Splicing Events, but Association of Protein Expression with Poor Prognosis. Wiley.